Literature DB >> 5040762

The 24-hour plasma thyrotrophin profile.

Y C Patel, F P Alford, H G Burger.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 5040762     DOI： 10.1042/cs0430071

Source DB:  PubMed          Journal:  Clin Sci        ISSN： 0009-9287            Impact factor:   6.124


× No keyword cloud information.
  23 in total

1.  Biochemistry on the human scale.

Authors:  Ken Sikaris
Journal:  Clin Biochem Rev       Date:  2010-11

Review 2.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

3.  Pulsatile secretion of thyrotropin in children.

Authors:  S Loche; V Cherubini; E Bartolotta; A Lampis; D Carta; P Tomasi; C Pintor
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

4.  Serum thyrotropin during daily life and in response to thyrotropin releasing hormone in normal subjects and juvenile diabetics.

Authors:  J Weeke; A P Hansen
Journal:  Diabetologia       Date:  1974-04       Impact factor: 10.122

5.  Periodicity of serum prolactin concentration.

Authors:  Y Patel; G Baker; F Alford; M Johns; H Burger
Journal:  Br Med J       Date:  1972-10-14

6.  Circadian rhythms of anterior pituitary hormone secretion: effects of dexamethasone.

Authors:  G Tolis; K Banovac; J M McKenzie; H Guyda
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

7.  Altered interrelationship of dopamine, prolactin, thyrotropin and thyroid hormone in schizophrenic patients.

Authors:  M L Rao; G Gross; G Huber
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

8.  Metabolic clearance and production rates of human thyrotropin.

Authors:  E C Ridgway; B D Weintraub; F Maloof
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

9.  Twenty-four hour variations of triiodothyronine (T3) levels in patients who had thyroid ablation for thyroid cancer, receiving T3 as suppressive treatment.

Authors:  B Busnardo; M E Girelli; F Bui; G P Zanatta; M Cimitan
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

10.  Suppression of the night increase in serum TSH during development of ketosis in diabetic patients.

Authors:  O Schmitz; K G Alberti; A B Hreidarsson; P Laurberg; J Weeke; H Orskov
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.